These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34691043)

  • 1. Altering the Immunogenicity of Hemagglutinin Immunogens by Hyperglycosylation and Disulfide Stabilization.
    Thornlow DN; Macintyre AN; Oguin TH; Karlsson AB; Stover EL; Lynch HE; Sempowski GD; Schmidt AG
    Front Immunol; 2021; 12():737973. PubMed ID: 34691043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies.
    Huang Y; Owino SO; Crevar CJ; Carter DM; Ross TM
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages.
    Corbett KS; Moin SM; Yassine HM; Cagigi A; Kanekiyo M; Boyoglu-Barnum S; Myers SI; Tsybovsky Y; Wheatley AK; Schramm CA; Gillespie RA; Shi W; Wang L; Zhang Y; Andrews SF; Joyce MG; Crank MC; Douek DC; McDermott AB; Mascola JR; Graham BS; Boyington JC
    mBio; 2019 Feb; 10(1):. PubMed ID: 30808695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem.
    Tan HX; Jegaskanda S; Juno JA; Esterbauer R; Wong J; Kelly HG; Liu Y; Tilmanis D; Hurt AC; Yewdell JW; Kent SJ; Wheatley AK
    J Clin Invest; 2019 Feb; 129(2):850-862. PubMed ID: 30521496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope.
    Bajic G; Maron MJ; Adachi Y; Onodera T; McCarthy KR; McGee CE; Sempowski GD; Takahashi Y; Kelsoe G; Kuraoka M; Schmidt AG
    Cell Host Microbe; 2019 Jun; 25(6):827-835.e6. PubMed ID: 31104946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions.
    Mittal N; Sengupta N; Malladi SK; Reddy P; Bhat M; Rajmani RS; Sedeyn K; Saelens X; Dutta S; Varadarajan R
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-Specific Glycan-Masking/Unmasking Hemagglutinin Antigen Design to Elicit Broadly Neutralizing and Stem-Binding Antibodies Against Highly Pathogenic Avian Influenza H5N1 Virus Infections.
    Chen TH; Yang YL; Jan JT; Chen CC; Wu SC
    Front Immunol; 2021; 12():692700. PubMed ID: 34335603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody.
    Raymond DD; Bajic G; Ferdman J; Suphaphiphat P; Settembre EC; Moody MA; Schmidt AG; Harrison SC
    Proc Natl Acad Sci U S A; 2018 Jan; 115(1):168-173. PubMed ID: 29255041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
    Broecker F; Liu STH; Sun W; Krammer F; Simon V; Palese P
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30045991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epitope-enriched immunogen expands responses to a conserved viral site.
    Caradonna TM; Ronsard L; Yousif AS; Windsor IW; Hecht R; Bracamonte-Moreno T; Roffler AA; Maron MJ; Maurer DP; Feldman J; Marchiori E; Barnes RM; Rohrer D; Lonberg N; Oguin TH; Sempowski GD; Kepler TB; Kuraoka M; Lingwood D; Schmidt AG
    Cell Rep; 2022 Nov; 41(6):111628. PubMed ID: 36351401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
    Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.
    Zost SJ; Wu NC; Hensley SE; Wilson IA
    J Infect Dis; 2019 Apr; 219(Suppl_1):S38-S45. PubMed ID: 30535315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin.
    Brazzoli M; Magini D; Bonci A; Buccato S; Giovani C; Kratzer R; Zurli V; Mangiavacchi S; Casini D; Brito LM; De Gregorio E; Mason PW; Ulmer JB; Geall AJ; Bertholet S
    J Virol; 2016 Jan; 90(1):332-44. PubMed ID: 26468547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes.
    Chiba S; Kong H; Neumann G; Kawaoka Y
    mBio; 2023 Aug; 14(4):e0062223. PubMed ID: 37466314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Guided Molecular Grafting of a Complex Broadly Neutralizing Viral Epitope.
    Bajic G; Maron MJ; Caradonna TM; Tian M; Mermelstein A; Fera D; Kelsoe G; Kuraoka M; Schmidt AG
    ACS Infect Dis; 2020 May; 6(5):1182-1191. PubMed ID: 32267676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfide isomerase ERp57 improves the stability and immunogenicity of H3N2 influenza virus hemagglutinin.
    Wu J; Wang Y; Wei Y; Xu Z; Tan X; Wu Z; Zheng J; Liu GD; Cao Y; Xue C
    Virol J; 2020 Apr; 17(1):55. PubMed ID: 32316996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model.
    Roubidoux EK; Carreño JM; McMahon M; Jiang K; van Bakel H; Wilson P; Krammer F
    mBio; 2021 Feb; 12(1):. PubMed ID: 33593972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prevalent Focused Human Antibody Response to the Influenza Virus Hemagglutinin Head Interface.
    McCarthy KR; Lee J; Watanabe A; Kuraoka M; Robinson-McCarthy LR; Georgiou G; Kelsoe G; Harrison SC
    mBio; 2021 Jun; 12(3):e0114421. PubMed ID: 34060327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.